Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
- 28 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 27 (12), 1125-1133
- https://doi.org/10.1038/s41594-020-0505-6
Abstract
The amyloid cascade hypothesis, according to which the self-assembly of amyloid-β peptide (Aβ) is a causative process in Alzheimer’s disease, has driven many therapeutic efforts for the past 20 years. Failures of clinical trials investigating Aβ-targeted therapies have been interpreted as evidence against this hypothesis, irrespective of the characteristics and mechanisms of action of the therapeutic agents, which are highly challenging to assess. Here, we combine kinetic analyses with quantitative binding measurements to address the mechanism of action of four clinical stage anti-Aβ antibodies, aducanumab, gantenerumab, bapineuzumab and solanezumab. We quantify the influence of these antibodies on the aggregation kinetics and on the production of oligomeric aggregates and link these effects to the affinity and stoichiometry of each antibody for monomeric and fibrillar forms of Aβ. Our results reveal that, uniquely among these four antibodies, aducanumab dramatically reduces the flux of Aβ oligomers.This publication has 51 references indexed in Scilit:
- BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide*Online Journal of Public Health Informatics, 2012
- Inhibition of Amyloid FormationJournal of Molecular Biology, 2012
- An Analytical Solution to the Kinetics of Breakable Filament AssemblyScience, 2009
- Refolding of Npro fusion proteinsBiotechnology & Bioengineering, 2009
- A facile method for expression and purification of the Alzheimer’s disease‐associated amyloid β‐peptideThe FEBS Journal, 2009
- The Brichos Domain-containing C-terminal Part of Pro-surfactant Protein C Binds to an Unfolded Poly-Val Transmembrane SegmentOnline Journal of Public Health Informatics, 2006
- Determination of β-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass SpectrometryJournal of Proteome Research, 2006
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- MOLMOL: A program for display and analysis of macromolecular structuresJournal of Molecular Graphics, 1996
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992